Colorectal Carcinoma (M1)

Ovarian Carcinoma (M2)

Service under development

Endometrial Cancer

M215.2 MLH1 promoter hypermethylation

Non-Small Cell Lung Cancer (M4)

  • Cytogenetic Tests, available for urgent cases and those where a result is not available using RNAseq or other appropriate testing.
    • ROS1 rearrangement FISH (M4.6)
    • EML4-ALK FISH (M4.10); undertaken using an ALK breakapart probe only, therefore the partner gene is not identifiable
  • Molecular Genetic Tests

Mucoepidermoid Carcinoma (M6)

MAML2 rearrangement FISH (M6.1), available for urgent cases and those where a result is not available using RNAseq or other appropriate testing.

Melanoma (M7)

Uveal Melanoma (M187)

BRAF hotspot (M187.2)

Gastrointestinal Stromal Tumour (M8)

Targeted hotspot panel (KIT, PDGFRA) (M8.1)

Adenoid Cystic Carcinoma (M16)

MYB-NFIB or MYBL1-NFIB FISH (M16.1); undertaken using MYB, MYBL1 & NFIB breakapart probes, available for urgent cases and those where a result is not available using RNAseq or other appropriate testing.

Secretory Carcinoma (Salivary Gland) (M17)

ETV6-NTRK3 FISH (M17.1); undertaken using ETV6 & NTRK3 breakapart probes, available for urgent cases and those where a result is not available using RNAseq or other appropriate testing.

Renal Cell Carcinoma - Adult (M18)

  • TFE3 rearrangement FISH (M18.1)
  • Chromosome 3 FISH (M18.3)
  • Chromosome 8 FISH (M18.4), available for urgent cases and those where a result is not available using RNAseq or other appropriate testing.
  • Chromosome 7 & 17 FISH (M18.5)
  • TFEB rearrangement FISH (M18.7)